Please login to the form below

Not currently logged in
Email:
Password:

Hywel Day joins Napp Pharmaceuticals

Moves from Mundipharma to take up managing director role

Napp Pharmaceuticals Hywel DayNapp Pharmaceuticals has appointed Hywel Day as its new managing director.

It’s a return to Napp for Day, who spent 10 years at Napp from 2003, before moving to Mundipharma.

At that company he served in a general manager role, based in The Netherlands, where he led the business through a substantial transformation, which involved a significant cultural shift and a diversification of the business portfolio.

Day said: “To be given the opportunity to lead a top UK pharmaceutical company is incredibly exciting. Not only is Napp a company with a long heritage of providing innovative, high-quality medicines to patients, but it is also a great place to work.

“I’m looking forward to working with a great bunch of intelligent, diligent and fun people - together, we will continue to nurture Napp’s values of striving for excellence and delivering on our promises to the NHS, patients, our business partners and each other.”

9th March 2017

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Nobull Communications

Switched on Creative Communications. With an encyclopedic working knowledge of pharmaceutical industry rules and regulations, we create dynamic, intuitive and...

Latest intelligence

OUTiCO win Best in UK Pharmaceutical Outsourcing award
The Corporate LiveWire Healthcare and Life Sciences Awards celebrate global companies and individuals who have excelled over the past 12 months....
artificial-intelligence-in-healthcare.jpg
Artificial Intelligence in Healthcare
Artificial intelligence is already out-diagnosing experts, but would you put a computer in charge of your healthcare? The good, the bad; we take a look....
World Pancreatic Cancer Day 2018: Combating misconceptions in pancreatic cancer
Patients diagnosed with pancreatic cancer face a dismal prognosis, with the disease having the lowest survival rate of all major cancers. In spite of this, pancreatic cancer research is chronically...

Infographics